key and novel finding effectively refutes this hypothesis. NHD had no effect on plasma concentrations of the NOS inhibitor ADMA yet increased both EDV and EIV. This dissociation was present within 1 month of commencing NHD.
This interpretation is consistent with several previous in vivo and in vitro findings. In CHD patients, endothelial NO generation is not decreased, when compared with control subjects, despite higher circulating ADMA concentrations. 16, 17 Cross et al 18 hypothesized that exogenous administration of L-arginine might improve endothelial function in patients with chronic kidney failure by overcoming inhibition of endothelial NO synthases by AMDA. However, acute local or systemic administration of L-arginine did not improve EDV in patients' resistance or conduit arteries. Another group examined responses to acetylcholine in vessels isolated from ESRD patients. Endothelial responsiveness was inhibited by calcium gated potassium channel blockade but not by inhibitors of NOS (ie, N G -monomethyl-L-aginine [L-NMMA] or ADMA). 19 Thus, substances other than inhibitors of NOS appear to be primarily responsible for the profound attenuation of EDV in ESRD patients.
The ability of more sustained dialysis to clear ADMA from the circulation has been questioned. Kielstein et al 20 studied 30 ESRD patients and analyzed the removal rates of ADMA by conventional and extended hemodialysis. These investigators found the dialysance of ADMA to be much lower than anticipated on the basis of its molecular weight, because of significant protein binding; its behavior therefore appeared similar to that of middle or large molecules. This is the first study to demonstrate that improvement in endothelial and vascular smooth muscle vasodilator responsiveness in ESRD occurs independently of any concurrent changes in circulating ADMA. This finding therefore calls into question the concept that increased plasma ADMA concentrations contribute importantly to the profound impairment of endothelium-dependent vasodilation in ESRD patients receiving CHD. 
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